1. Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of β-catenin expression via EP3-4 receptor
   MINGZHAN DU et al, 2015, Oncology Reports CrossRef
2. Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development
   Mario M. Alba et al, 2023, Frontiers in Physiology CrossRef
3. Identifying the biomarkers and pathways associated with hepatocellular carcinoma based on an integrated analysis approach
   Yichen Yang et al, 2021, Liver International CrossRef
4. Regulation of PGE2 signaling pathways and TNF-alpha signaling pathways on the function of bone marrow-derived dendritic cells and the effects of CP-25
   Ying Li et al, 2015, European Journal of Pharmacology CrossRef
5. Synergistic antitumor effect of resveratrol and sorafenib on hepatocellular carcinoma through PKA/AMPK/eEF2K pathway
   Meili Gao et al, 2021, Food & Nutrition Research CrossRef
6. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
   G O'Callaghan et al, 2015, British Journal of Pharmacology CrossRef
7. The NADPH Oxidase Inhibitor Apocynin Suppresses Preneoplastic Liver Foci of Rats
   Satoshi Fuji et al, 2017, Toxicologic Pathology CrossRef
8. cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment
   Hongying Zhang et al, 2024, Journal of Hematology & Oncology CrossRef
9. The Roles of Tumor-Associated Macrophages in Prostate Cancer
   Chenglin Han et al, 2022, Journal of Oncology CrossRef
10. Regulation of mPGES‑1 composition and cell growth via the MAPK signaling pathway in jurkat cells
    Yi‑Qing Li et al, 2018, Experimental and Therapeutic Medicine CrossRef
11. Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma
    Filippo Pelizzaro et al, 2021, Clinical and Experimental Medicine CrossRef
12. Cyclooxygenase 2 in liver dysfunction and carcinogenesis: Facts and perspectives
    Paloma Martín-Sanz et al, 2017, World Journal of Gastroenterology CrossRef
13. Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling
    Xia Zhou et al, 2022, Frontiers in Molecular Biosciences CrossRef
14. microRNA as a systemic intervention in the specific breast cancer subtypes with C‐MYC impacts; introducing subtype‐based appraisal tool
    Vida Pourteimoor et al, 2018, Journal of Cellular Physiology CrossRef
15. Emerging Roles of G Protein-Coupled Receptors in Hepatocellular Carcinoma
    Wen-Ting Peng et al, 2018, International Journal of Molecular Sciences CrossRef
16. Transcriptional regulation of microsomal prostaglandin E synthase 1 by the proto-oncogene, c-myc, in the pathogenesis of inflammation and cancer
    M. Ramanan et al, 2017, Biochemical and Biophysical Research Communications CrossRef
17. Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular Carcinoma
    Chao Chen et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
18. Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
    Gabriel Siracusano et al, 2020, Vaccines CrossRef
19. Prostaglandin E2 promotes pathological retinal neovascularisation via EP4R-EGFR-Gab1-AKT signaling pathway
    Tianhua Xie et al, 2021, Experimental Eye Research CrossRef
20. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway
    Song Xu et al, 2018, Molecular Medicine Reports CrossRef
21. Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy
    Shihong Peng et al, 2022, Clinical Cancer Research CrossRef
22. Modulatory effects of G protein–coupled receptor in hepatocellular carcinoma
    Vidya Murugesan et al, 2022, Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma CrossRef
23. Acetylsalicylic-acid (ASA) regulation of osteo/odontogenic differentiation and proliferation of human dental pulp stem cells (DPSCs) in vitro
    Mladen Vukovic et al, 2022, Archives of Oral Biology CrossRef
24. Advanced drug delivery systems in hepatocellular carcinoma
    Dhrubojyoti Mukherjee et al, 2021, Advanced Drug Delivery Systems in the Management of Cancer CrossRef
25. Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation
    Yu-Ting Tsai et al, 2022, Journal of Biomedical Science CrossRef
26. Interplay between inflammation and cancer
    Igor Piotrowski et al, 2020, Reports of Practical Oncology & Radiotherapy CrossRef